Camp4 Therapeutics Corporation · NASDAQ:CAMP

Gold Kelly bought 10,000 Camp4 Therapeutics Corporation shares (Form 4)

Traded Aug 31, 2026 · Filed Sep 2, 2026

On Aug 31, 2026, Gold Kelly (Chief Financial Officer) bought 10,000 Camp4 Therapeutics Corporation shares at US$3.96 for US$39,600, leaving 10,000 shares. Filed Sep 2, 2026 (Form 4).

Bought
10,000 shares
Price
US$3.96
Value
US$39,600
Holding after
10,000 shares (held indirectly)
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 31, 2026Common StockBuy10,000US$3.9610,000Indirect

Source

View original at SEC

Related